Ergawealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $488K | Buy |
626
+24
| +4% | +$18.7K | 0.22% | 46 |
|
|
2025
Q1 | $497K | Sell |
602
-18
| -3% | -$14.9K | 0.25% | 39 |
|
|
2024
Q4 | $479K | Sell |
620
-9
| -1% | -$6.95K | 0.24% | 40 |
|
|
2024
Q3 | $557K | Sell |
629
-2
| -0.3% | -$1.77K | 0.28% | 36 |
|
|
2024
Q2 | $571K | Sell |
631
-4
| -0.6% | -$3.62K | 0.31% | 33 |
|
|
2024
Q1 | $494K | Buy |
635
+10
| +2% | +$7.78K | 0.27% | 32 |
|
|
2023
Q4 | $364K | Sell |
625
-2
| -0.3% | -$1.17K | 0.22% | 36 |
|
|
2023
Q3 | $337K | Sell |
627
-23
| -4% | -$12.4K | 0.23% | 37 |
|
|
2023
Q2 | $305K | Hold |
650
| – | – | 0.21% | 35 |
|
|
2023
Q1 | $223K | Hold |
650
| – | – | 0.18% | 43 |
|
|
2022
Q4 | $238K | Buy |
+650
| New | +$238K | 0.22% | 42 |
|